As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

As usage of the medications increases, Circana research indicates deli and produce could be bright spots for spending.

A Danish study has found that semaglutide, which controls blood glucose while ensuring weight loss, is associated with a ...

This could start to bring down the cost of brand-name competitors—here's who may get to use it, and one major difference from ...

"It was the strangest feeling, because I never felt better about my physical appearance, but I also didn't want my husband to ...

THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of ...

The Study is designed mainly to determine whether Lexaria’s proprietary DehydraTECH technology improves the safety and effectiveness of existing GLP-1 drugs. “Achieving the first patient, first dose ...

Mer­ck is fi­nal­ly mak­ing a move in obe­si­ty by li­cens­ing an oral GLP-1 can­di­date, though it’s hap­pen­ing years af­ter some of its big phar­ma peers … ...

Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for a preclinical drug. The Big Pharma already has efinopegdutide, a dual GLP-1 ...

RAHWAY, N.J., December 18, 2024--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, today announced ...